A common asthma medication, taken daily by millions without a second thought, may carry within it an unexpected power against cancer. Researchers at Northwestern University have found that montelukast can disrupt the molecular trick tumors use to turn the body's own immune cells into their protectors — effectively retraining those cells to fight back. Published in Nature Cancer, the findings span five cancer types in mouse models and are bolstered by patterns observed in human patient data, suggesting the mechanism may not be confined to the laboratory. Because the drug's safety is already est
Infobae
· May 21, 2026
· health
· 3 min de leitura
High
Apuração: Caracterizado
Asthma drug shows promise halting tumor growth in mouse studies
◉
Health & Medicine
2812 artigos relacionados
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% correspondência
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% correspondência
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% correspondência
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% correspondência
Functional Medicine Shifts Focus to Patient as Active Participant in H…
El País · 90% correspondência
Cobertura Relacionada
El Mostrador · Aug 23
Guía de alimentos a limitar para proteger la salud cardiovascular
Expertos recomiendan limitar embutidos, bebidas azucaradas y ultraprocesados para reducir riesgos cardiovasculares. La a…
OkDiario · Aug 23 La boca seca no es una molestia menor: cuándo consultar al médicoLa xerostomía o boca seca es un problema infradiagnosticado que afecta a una de cada tres personas mayores de 60 años, f…
Segre.com · Aug 23 Programa pionero de ejercicio monitorizado mejora la salud cardiopulmonar en LleidaUn programa pionero en Lleida utiliza ejercicio físico monitorizado y análisis de 30 variables metabólicas para mejorar …
El País · Aug 23 No habrá una vacuna contra el cáncer, sino una distinta para cada paciente y tumorModerna y MSD avanzan hacia la aprobación de una vacuna de ARN mensajero personalizada contra el melanoma que reduce un …
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical breakthrough in cancer treatment has no direct geopolitical implications; Northwestern's asthma drug discovery is a scientific advancement without immediate international power dynamics.
Escalation Risk
low
Confidence
HIGH
No significant geopolitical shifts. This is a domestic U.S. scientific development that may have future healthcare industry implications.
Lente Econômica
📈
FDA-approved asthma drug montelukast shows potential as cancer treatment by reprogramming immune cells, potentially creating new market opportunities in oncology while affecting existing asthma medication demand.
Market Signal
bullish
Confidence
MED
Pharmaceutical/Oncology
Pharmaceutical/Respiratory
Healthcare/Medical Research
Biotechnology
Patients with asthma/allergies may face supply constraints or price increases if montelukast demand surges from cancer applications. Potential future access to repurposed, lower-cost cancer treatments could reduce oncology treatment expenses for patients.
FDA may expedite clinical trials given existing drug approval status. Patent/exclusivity considerations for new cancer indications could emerge. Healthcare systems may need to manage montelukast allocation between respiratory and oncology uses. Potential for rapid regulatory pathway (breakthrough therapy designation) if clinical trials show efficacy.